tiprankstipranks
Trending News
More News >
Fennec Pharmaceuticals (TSE:FRX)
TSX:FRX
Canadian Market

Fennec Pharmaceuticals (FRX) Income Statement

Compare
17 Followers

Fennec Pharmaceuticals Income Statement

Last quarter (Q4 2024), Fennec Pharmaceuticals's total revenue was $7.92M, a decrease of -18.59% from the same quarter last year. In Q4, Fennec Pharmaceuticals's net income was $-1.99M. See Fennec Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 47.54M$ 21.25M$ 1.53M$ 0.00$ 170.00K
Gross Profit
$ 44.35M$ 19.99M$ 1.45M$ 0.00$ 170.00K
Operating Expenses
$ 41.79M$ 32.76M$ 24.04M$ 17.22M$ 18.05M
Depreciation and Amortization
$ 800.00K$ 287.00K$ 149.00K$ 17.22M$ 402.00K
EBITDA
$ 4.80M$ -12.65M$ -22.74M$ -17.18M$ -17.98M
Operating Income
$ 2.57M$ -12.77M$ -22.59M$ -17.22M$ -17.89M
Other Income/Expenses
$ -2.64M$ -3.27M$ -1.13M$ -123.00K$ -224.00K
Pretax Income
$ -71.00K$ -16.05M$ -23.71M$ -17.35M$ -18.11M
Net Income
$ -436.00K$ -16.05M$ -23.86M$ -17.46M$ -18.11M
Per Share Metrics
Basic EPS
$ -0.02$ -0.60$ -0.91$ -0.67$ -0.76
Diluted EPS
$ -0.02$ -0.60$ -0.91$ -0.67$ -0.76
Weighted Average Shares Outstanding
21.80M 26.57M 26.27M 25.89M 23.70M
Weighted Average Shares Outstanding (Diluted)
27.30M 26.57M 26.27M 26.01M 23.70M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis